Last $7.09 USD
Change Today +0.28 / 4.11%
Volume 3.4M
ARIA On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Martin J. Duvall

Chief Commercial Officer and Executive Vice President, Ariad Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

52$1,700,637
As of Fiscal Year 2013

Background*

Mr. Martin J. Duvall, also known as Marty, serves as Chief Commercial Officer and Executive Vice President at Ariad Pharmaceuticals Inc. and served as its Senior Vice President of Commercial Operations since September 2011. Mr. Duvall served as Senior Vice President of Global Marketing & International Commercial Operations at Abraxis BioScience, Inc. since May 2009. Mr. Duvall served as Senior Vice President of Commercial Strategy & Development of MGI Pharma Inc. from ...

Read Full Background

Corporate Headquarters*

26 Landsdowne Street
Cambridge, Massachusetts 02139

United States

Phone: 617-494-0400
Fax: 617-494-8144

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MA
Johns Hopkins University
MBA
University of Kansas
BS
Muhlenberg College

Other Affiliations*

Annual Compensation*

Salary$427,262
Total Annual Compensation$427,262

Stock Options*

Restricted Stock Awards$501,360
All Other Compensation$23,457
Exercisable Options53,334
Unexercisable Options139,666
Unexercisable Options Value$88,550
Total Value of Options$88,550
Total Number of Options193,000

Total Compensation*

Total Annual Cash Compensation$450,719
Total Short Term Compensation$427,262
Other Long Term Compensation$524,817
Total Calculated Compensation$1,700,637
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARIA:US $7.09 USD +0.28

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Arena Pharmaceuticals, Inc.
$725.0K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$548.8K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Aijaz Tobaccowalla Managing Director, Additional Director, Member of Board Administrative Committee and Member of Nomination & Remuneration Committee
Pfizer Limited
30.3M
Michael L. Babich Chief Executive Officer, President and Director
INSYS Therapeutics, Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARIAD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.